Literature DB >> 20948510

The serotonin 5-HT2C receptor in medial prefrontal cortex exerts rheostatic control over the motivational salience of cocaine-associated cues: new observations from preclinical animal research.

Kathryn A Cunningham1, Marcy J Bubar, Noelle C Anastasio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20948510      PMCID： PMC3055336          DOI： 10.1038/npp.2010.119

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  6 in total

1.  Stimulation of medial prefrontal cortex serotonin 2C (5-HT(2C)) receptors attenuates cocaine-seeking behavior.

Authors:  Nathan S Pentkowski; Felicia D Duke; Suzanne M Weber; Lara A Pockros; Andrew P Teer; Elizabeth C Hamilton; Kenneth J Thiel; Janet L Neisewander
Journal:  Neuropsychopharmacology       Date:  2010-06-02       Impact factor: 7.853

2.  Serotonin 5-HT2C receptor protein expression is enriched in synaptosomal and post-synaptic compartments of rat cortex.

Authors:  Noelle C Anastasio; Maria Fe Lanfranco; Marcy J Bubar; Patricia K Seitz; Sonja J Stutz; Andrew G McGinnis; Cheryl S Watson; Kathryn A Cunningham
Journal:  J Neurochem       Date:  2010-03-24       Impact factor: 5.372

Review 3.  The neural basis of addiction: a pathology of motivation and choice.

Authors:  Peter W Kalivas; Nora D Volkow
Journal:  Am J Psychiatry       Date:  2005-08       Impact factor: 18.112

4.  Lorcaserin (APD356), a selective 5-HT(2C) agonist, reduces body weight in obese men and women.

Authors:  Steven R Smith; Warren A Prosser; David J Donahue; Michael E Morgan; Christen M Anderson; William R Shanahan
Journal:  Obesity (Silver Spring)       Date:  2008-12-04       Impact factor: 5.002

Review 5.  Serotonergic mechanisms in addiction-related memories.

Authors:  Bríd A Nic Dhonnchadha; Kathryn A Cunningham
Journal:  Behav Brain Res       Date:  2008-07-01       Impact factor: 3.332

Review 6.  Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.

Authors:  Marcy J Bubar; Kathryn A Cunningham
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453
  6 in total
  6 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

2.  Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT2C Receptor.

Authors:  Christopher T Wild; Joanna M Miszkiel; Eric A Wold; Claudia A Soto; Chunyong Ding; Rachel M Hartley; Mark A White; Noelle C Anastasio; Kathryn A Cunningham; Jia Zhou
Journal:  J Med Chem       Date:  2018-04-13       Impact factor: 7.446

3.  Effects of escitalopram on attentional bias to cocaine-related stimuli and inhibitory control in cocaine-dependent subjects.

Authors:  Shijing Liu; Scott D Lane; Joy M Schmitz; Kathryn A Cunningham; Vineeth P John; F Gerard Moeller
Journal:  J Psychopharmacol       Date:  2013-06-12       Impact factor: 4.153

4.  Short-term quetiapine treatment alters the use of reinforcement signals during risky decision-making and promotes the choice of negative expected values in healthy adult males.

Authors:  Philippa L Rock; Catherine J Harmer; Sarah F B McTavish; Guy M Goodwin; Robert D Rogers
Journal:  J Neurosci       Date:  2013-09-25       Impact factor: 6.167

5.  Citalopram for treatment of cocaine use disorder: A Bayesian drop-the-loser randomized clinical trial.

Authors:  Robert Suchting; Charles E Green; Constanza de Dios; Jessica Vincent; F Gerard Moeller; Scott D Lane; Joy M Schmitz
Journal:  Drug Alcohol Depend       Date:  2021-09-23       Impact factor: 4.492

6.  5HT-2C agonist lorcaserin decreases cannabis self-administration in daily cannabis smokers.

Authors:  Caroline A Arout; Ziva D Cooper; Stephanie Collins Reed; Richard W Foltin; Sandra D Comer; Frances R Levin; Margaret Haney
Journal:  Addict Biol       Date:  2021-01-03       Impact factor: 4.093
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.